Advanced Inhalation to launch on NASDAQ

Israeli biotech Advanced Inhalation Therapies (AIT), plans to raise $12 million on NASDAQ. AIT (new name Beyond Air) develops products for the treatment of respiratory infections including Cystic Fibrosis. See previous newsletter articles (here) of its Nitric Oxide treatment.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *